Lunan Pharmaceutical Group | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Trial results

24 January 2024

OncoC4 takes its Siglec-10 bet into the clinic

The anti-Siglec-10 MAb ONC-841 features among the latest crop of first-in-human trial initiations.

Subscribe to Lunan Pharmaceutical Group